Congress is facing renewed pressure to preserve access to hemp-derived THC products—and establish rules for the businesses selling them. According to Marijuana Moment’s October 9 report by Tom Angell, the Marijuana Policy Project (MPP) is asking supporters to contact Congress and push for regulation instead of...
Federal hemp restrictions could redirect some spending toward licensed cannabis dispensaries. In Florida, however, that shift depends on whether customers qualify for the state’s medical marijuana program. Lost hemp sales do not automatically become dispensary sales. For investors, a shrinking hemp market might look like an...
Florida has another round of marijuana legalization proposals on the table. Actually, three. Before anyone starts planning a recreational dispensary grand opening, there is an important detail: these are proposed constitutional amendments targeting 2028. Filing a proposal does not put it on the ballot, and it...
Florida is approaching one million medical marijuana patients, but slower enrollment growth is bringing new attention to patient access and competition. Here’s why Tampa Bay should care. Almost a million patients is a big milestone. Whether those patients can afford reliable access is an equally important...
A Florida congressman’s call to examine federal drug classifications is expanding the conversation beyond cannabis. Here is how to understand the headlines without getting ahead of the law. Washington is talking about cannabis again. This time, the conversation comes with a bigger question: why stop at...
You tried CBD. You waited. Nothing happened. Before you decide CBD is a scam, there are a few things you should know. Estimated reading time: 7 minutes Let's be honest. You've probably heard someone say, "I tried CBD once, and it didn't do anything for me." Maybe you've...
Psychedelic medicine used to sound like a fringe conversation. Now companies including Eli Lilly and AbbVie are investing in treatments inspired by psychedelic research. That is a big change. It also raises a fair question: Does a pharmaceutical company’s investment mean these treatments are proven? No. It...
Cancer care involves more than treating a tumor. A diagnosis can bring anxiety, depression, and difficult questions about the future. Researchers are studying whether psilocybin-assisted therapy could help some patients face that emotional weight. Early clinical trials have reported encouraging results for depression and anxiety in...
Every couple has that conversation. You know the one: it starts with a small frustration and somehow ends with a detailed review of everything that happened since 2019. That is part of why MDMA-assisted couples therapy is getting attention. In a recent report from Israel, couples...
If you saw news about an FDA hearing on psychedelic therapy and thought, “Wait, is this happening now?” you’re asking the right question. The FDA held a public hearing on September 14, 2026, to hear perspectives on the potential future therapeutic use of psychedelic drug products...